Document Detail


Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage.
MedLine Citation:
PMID:  15829916     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cortical spreading depression (CSD) is thought to be a neuronal mechanism that expands the penumbra zone after focal brain ischemia and that causes migraine aura. Both adrenergic agonists and antagonists significantly influence the size of the penumbra zone and decline the frequency of migraine. To study whether these compounds act by influencing CSD, we applied different drugs topically to an area of the exposed cortex of anesthetized adult rats and observed the migration of CSD-related DC potential deflections across the treated area. The adrenergic agonist norepinephrine (1 mmol/L) and the alpha(2)-agonist clonidine (0.56 mmol/L) blocked reversibly the migration of CSD. The beta-blocker propranolol (250 micromol/L to 1 mmol/L) dose-dependently diminished migration velocity or even blocked migration of CSD. The CSD blockade by the alpha(2)-antagonist yohimbine (1.75 mmol/L) was because of its action on inhibitory 5-HT(1A) receptors. None of the substances in the concentrations used had influence on regional cerebral blood flow or on systemic arterial blood pressure. The data suggest that the interference of these compounds with CSD may contribute to their beneficial therapeutic effect. The effect of beta-receptor antagonists in human migraine needs further exploration, since these drugs also work in migraine without aura.
Authors:
Frank Richter; Oskar Mikulik; Andrea Ebersberger; Hans-Georg Schaible
Related Documents :
1375596 - Effect of neuropeptides released from sensory nerves on blood flow in the rat airway mi...
16865866 - Safety of occluded 4% liposomal lidocaine cream.
1282626 - Antagonizing and measurement: approaches to understanding of hemodynamic effects of kin...
14784536 - Pressor substances in arterial hypertension. ii. demonstration of pherentasin, a vasoac...
6546766 - Surfactant and pulmonary blood flow distributions following treatment of premature lamb...
2690966 - Perihemorheology: the bridge between the vessel-blood organ and the organs it penetrates.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism     Volume:  25     ISSN:  0271-678X     ISO Abbreviation:  J. Cereb. Blood Flow Metab.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-24     Completed Date:  2005-09-21     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8112566     Medline TA:  J Cereb Blood Flow Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1225-35     Citation Subset:  IM    
Affiliation:
Institute of Physiology-Neurophysiology, Friedrich Schiller University Jena, Jena, Germany. FRIC@mti.uni-jena.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic Antagonists / pharmacology*
Adrenergic alpha-Agonists / pharmacology*
Adrenergic beta-Antagonists / pharmacology
Animals
Blood Pressure / drug effects
Brain Damage, Chronic / etiology,  prevention & control*
Brain Ischemia / pathology*
Cerebral Cortex / drug effects,  physiology
Cerebrovascular Circulation / drug effects
Clonidine / pharmacology
Cortical Spreading Depression / drug effects*
Drug Interactions
Electrodes, Implanted
Imidazoles / pharmacology
Indoles / pharmacology
Isoindoles
Male
Migraine Disorders / physiopathology*,  prevention & control*
Norepinephrine / pharmacology,  physiology*
Piperazines / pharmacology
Propranolol / pharmacology
Rats
Rats, Wistar
Receptor, Serotonin, 5-HT1A / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Adrenergic Antagonists; 0/Adrenergic alpha-Agonists; 0/Adrenergic beta-Antagonists; 0/Imidazoles; 0/Indoles; 0/Isoindoles; 0/Piperazines; 112692-38-3/Receptor, Serotonin, 5-HT1A; 115338-32-4/1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine; 118343-19-4/BRL 44408; 4205-90-7/Clonidine; 51-41-2/Norepinephrine; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oxidative stress transiently decreases the IKK complex (IKKalpha, beta, and gamma), an upstream comp...
Next Document:  Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-pho...